Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13

Businesswire05:05

Vertex Gets Expanded FDA Approval for Cystic Fibrosis Treatment

WSJ12/21 05:00

Vertex Announces US FDA Approval of ALYFTREK, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Businesswire12/21 04:46

Vertex Announces U.S. FDA Approval for TRIKAFTA (Elexacaftor/tezacaftor/ivacaftor and Ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

Businesswire12/21 04:35

Vertex(VERX.US)非成瘾性止痛药遭遇“安慰剂效应” 分析师称其带来挫折

智通財経12/19 21:29

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Businesswire12/19 19:00